(lp0
S"The Reason Behind BioCryst Pharmaceuticals, Inc.'s 12% Pop Higher Motley Fool - Mar 8, 2017 Shares of BioCryst Pharmaceuticals , a biotech company that develops small-molecule drugs to block enzymes involved in disease proliferation, surged as much as 12% today after a report was issued that a highly pathogenic H5N1 bird flu&nbsp;...DE Shaw is Buying Biocryst Pharmaceuticals Inc.  Shares - Small Cap Exclusive "
p1
aS"Here's Why BioCryst Pharmaceuticals Inc. Catapulted Higher by as Much as 17% Motley Fool - Feb 28, 2017 Shares of BioCryst Pharmaceuticals , a biopharmaceutical company primarily focused on the development of small-molecule drugs that block enzymes associated with the development of diseases, catapulted higher by as much as 17%&nbsp;..."
p2
aS'BioCryst Pharmaceuticals Inc.  Breaks into New 52-Week High on March 20 ... Equities.com - 8 hours ago Shares of BioCryst Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $9.21. Shares closed at $9.20 after opening at $8.82 for a move of 3.95%.'
p3
aS'Option Market Alert: BioCryst Pharmaceuticals Inc Implied Price Swing Hits An ... CML News - Mar 19, 2017 Risk Alert: Before we dive into any analysis we simply note that BioCryst Pharmaceuticals Inc  risk is elevated.'
p4
aS'BioCryst Pharmaceuticals, Inc.  Files An 8-K Entry into a ... Market Exclusive - Mar 17, 2017 BioCryst Pharmaceuticals, Inc.  is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases.BioCryst Pharmaceuticals, Inc.  Makes The Move To Publicize Its ... - Journal TranscriptInvestors Focused Stock: BioCryst Pharmaceuticals, Inc.  - Is stories'
p5
aS'Top Institutional Investors That Own BioCryst Pharmaceuticals, Inc.  Post Analyst - 10 hours ago BioCryst Pharmaceuticals, Inc.  reached 275% versus a 1-year low price of $2.48. The stock was last seen 0.57% higher, reaching at $8.85 on Mar. 17, 2017.Zacks Investment Research Downgrades BioCryst Pharmaceuticals, Inc.  to Hold - The Cerbat GemBioCryst Pharmaceuticals, Inc.  Reaches $9.20 After 8.00% Up Move ... - Wolcott Daily'
p6
aS'ATR Check for BioCryst Pharmaceuticals Inc  Davidson Register - 10 hours ago Active traders have a wide variety of technical indicators at their disposal for completing technical stock analysis. Presently, the 14-day ATR for BioCryst Pharmaceuticals Inc  is spotted at 0.56. First developed by J. Welles Wilder, the ATR may ...'
p7
aS'BioCryst Pharmaceuticals Inc.  Breaks into New 52-Week High on March 16 ... Equities.com - Mar 16, 2017 Shares of BioCryst Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $9.15. Shares closed at $8.80 after opening at $8.84 for a move of 0.69%.'
p8
aS'BioCryst Pharmaceuticals Inc.  Breaks into New 52-Week High on March 03 ... Equities.com - Mar 3, 2017 Shares of BioCryst Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $7.70. Shares closed at $7.68 after opening at $7.44 for a move of 3.5%.Stock On the Run: BioCryst Pharmaceuticals, Inc.  - HugoPressBioCryst Pharmaceuticals, Inc.  Stock Rating Upgraded by Zacks ... - The Cerbat Gem'
p9
aS'BioCryst Pharmaceuticals  Shares March Higher, Can It Continue? Yahoo Finance - Mar 15, 2017 BioCryst Pharmaceuticals, Inc. BCRX has been on the move lately as the stock has risen by 46.8% in the past four weeks, and it is currently trading well above its 20-Day SMA.'
p10
a.